author-photo

Meredith Y. Smith

Amgen

32

Papers

319

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients.

2021 Frontiers in Public Health
Show All
- Source
- Cite
- Save
Citations (5)
The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards.

2021 International Journal of Epidemiology
Show All
- Source
- Cite
- Save
Citations (0)
Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy

2021 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences

2021 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (2)
Quantitative Benefit-Risk Assessment: State of the Practice Within Industry.

2020 Therapeutic Innovation & Regulatory Science
Show All
- Source
- Cite
- Save
Citations (0)
The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studies.

2020 Pharmacoepidemiology and Drug Safety
Show All
- Source
- Cite
- Save
Citations (1)
Quantitative benefit-risk assessment: What methods are being used? How far has industry come?

2020
Show All
- Source
- Cite
- Save
Citations (1)
Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review

2020 Drug Safety
Show All
- Source
- Cite
- Save
Citations (5)
Dissemination and Implementation Science

2020
- Elaine H. Morrato
- Meredith Y. Smith
Show All
- Source
- Cite
- Save
Citations (0)
Factors and situations affecting the value of patient preference studies: semi-structured interviews in Europe and the US

2019 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (7)